NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT00528372 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00527254 Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient Status COMPLETED Phase NA
NCT00525629 The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome Status COMPLETED Phase NA
NCT00525330 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone Status COMPLETED Phase PHASE2
NCT00523393 Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells Status UNKNOWN Phase PHASE4
NCT00513630 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT00513214 Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1/PHASE2
NCT00508599 The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics Status COMPLETED Phase NA
NCT00508287 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT00506298 Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes Status COMPLETED Phase PHASE2
NCT00506194 Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control Status COMPLETED Phase NA
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00497198 Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00494663 A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes Status TERMINATED Phase PHASE2